Profile data is unavailable for this security.
About the company
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and laboratory product solutions. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. The Company's segments include Pharmaceutical and Medical. Its Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets.
- Revenue in USD (TTM)216.15bn
- Net income in USD639.00m
- Incorporated1979
- Employees48.00k
- LocationCardinal Health Inc7000 Cardinal PlDUBLIN 43017United StatesUSA
- Phone+1 (614) 757-3033
- Fax+1 (614) 757-6000
- Websitehttps://www.cardinalhealth.com/en.html
Mergers & acquisitions
Acquired company | CAH:NYQ since announced | Transaction value |
---|---|---|
Specialty Networks LLC | 4.52% | 1.20bn |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 10.45bn | 561.16m | 6.11bn | 28.05k | 11.47 | 1.33 | -- | 0.5845 | 2.49 | 2.49 | 46.45 | 21.48 | 0.9855 | 5.56 | 5.04 | 2,692,363.00 | 5.56 | 5.90 | 11.17 | 12.40 | 18.33 | 18.70 | 5.64 | 5.56 | 1.23 | -- | 0.3013 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
Shanghai Pharmaceuticals Holding Co Ltd | 35.27bn | 636.48m | 7.92bn | 47.88k | 13.53 | 0.9216 | -- | 0.2246 | 1.26 | 1.26 | 70.11 | 18.50 | 1.25 | 7.06 | 3.43 | 5,323,594.00 | 2.92 | 3.90 | 7.65 | 10.17 | 12.18 | 13.67 | 2.34 | 2.86 | 1.06 | 8.24 | 0.4002 | 31.20 | 7.49 | 12.13 | 10.28 | 9.79 | 5.99 | 9.93 |
Sinopharm Group Co Ltd | 82.65bn | 1.25bn | 8.14bn | 115.96k | 6.49 | 0.7875 | 3.03 | 0.0985 | 3.14 | 3.14 | 207.22 | 25.91 | 1.59 | 9.06 | 3.51 | 5,576,684.00 | 4.01 | 4.09 | 16.32 | 17.37 | 8.13 | 8.54 | 2.52 | 2.55 | 1.15 | 6.96 | 0.3801 | 12.46 | 8.05 | 11.61 | 6.19 | 9.18 | -- | 8.10 |
Zhangzhou Pientzhng Phrmctcl Co Ltd | 1.34bn | 390.81m | 19.27bn | 2.72k | 49.32 | 10.71 | -- | 14.39 | 4.68 | 4.68 | 16.04 | 21.56 | 0.6537 | 2.05 | 13.47 | 3,558,128.00 | 19.55 | 19.02 | 23.73 | 24.40 | 45.61 | 45.90 | 29.90 | 27.27 | 5.02 | -- | 0.0714 | 31.71 | 8.38 | 18.54 | 1.66 | 25.10 | 27.59 | 23.79 |
Cardinal Health Inc | 216.15bn | 639.00m | 27.37bn | 48.00k | 44.29 | -- | 20.44 | 0.1266 | 2.54 | 2.54 | 856.88 | -14.14 | 4.75 | 11.70 | 18.63 | 4,503,084.00 | 1.41 | -1.13 | 6.56 | -3.08 | 3.34 | 4.00 | 0.2966 | -0.2816 | 0.5017 | 31.29 | 3.70 | -- | 13.04 | 8.43 | 127.97 | -- | 4.61 | 1.40 |
Cencora Inc | 271.58bn | 1.87bn | 48.80bn | 42.00k | 26.64 | 53.52 | 16.58 | 0.1797 | 9.18 | 9.18 | 1,334.79 | 4.57 | 4.43 | 14.81 | 12.64 | 6,466,177.00 | 3.03 | 0.9542 | 13.95 | 3.95 | 3.37 | 3.14 | 0.6847 | 0.2178 | 0.5162 | 11.93 | 0.8183 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
McKesson Corp | 301.51bn | 3.00bn | 70.86bn | 45.00k | 24.43 | -- | 18.69 | 0.235 | 22.07 | 22.07 | 2,223.50 | -15.67 | 4.67 | 13.56 | 13.83 | 6,700,134.00 | 4.89 | 0.6349 | 21.92 | 2.21 | 4.01 | 5.04 | 1.05 | 0.1611 | 0.4959 | 15.38 | 1.40 | 144.13 | 4.83 | 5.84 | 218.41 | -- | -0.7704 | 10.25 |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 30.16m | 12.40% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 14.51m | 5.97% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 13.35m | 5.49% |
Geode Capital Management LLCas of 31 Dec 2023 | 5.44m | 2.24% |
Arrowstreet Capital LPas of 31 Dec 2023 | 4.70m | 1.93% |
BlackRock Advisors LLCas of 31 Dec 2023 | 4.51m | 1.85% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 3.76m | 1.55% |
Columbia Management Investment Advisers LLCas of 31 Dec 2023 | 3.68m | 1.51% |
Invesco Capital Management LLCas of 31 Dec 2023 | 3.25m | 1.34% |
Acadian Asset Management LLCas of 31 Dec 2023 | 3.13m | 1.29% |